We have learned of an anticipated drug shortage that may affect some epilepsy patients in Canada. The product shortage affects SABRIL (vigabatrin), in the 500 mg powder for oral solution only. Stock of 500 mg SABRIL tablets remains available. The shortage is expected to begin in early August, and at this time it is unknown…